This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $400 | Check With Us |
250mg | $600 | Check With Us |
500mg | $900 | Check With Us |
Cat #: V3880 CAS #: 1110766-97-6 Purity ≥ 98%
Description: Lusutrombopag (formerly known as S888711; S-888711; trade name: Mulpleta) is a novel orally bioavailable, small molecule agonist of thrombopoietin (TPO) receptor.
References: Kim ES, et al. Lusutrombopag: First Global Approval. Drugs. 2016 Jan;76(1):155-8.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 591.54 |
---|---|
Molecular Formula | C29H32Cl2N2O5S |
CAS No. | 1110766-97-6 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: ≥ 33 mg/mLr |
Water: N/Ar | |
Ethanol: N/A | |
SMILES Code | O=C(O)/C(C)=C/C1=C(Cl)C=C(C(NC2=NC(C3=CC=CC([C@@H](OCCCCCC)C)=C3OC)=CS2)=O)C=C1Cl |
Synonyms | S-888711; S888711; S 888711; Trade name: Mulpleta |
Protocol | In Vitro | usutrombopag acts selectively on the human TPO receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels. |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.6905 mL | 8.4525 mL | 16.9050 mL | 33.8101 mL |
5mM | 0.3381 mL | 1.6905 mL | 3.3810 mL | 6.7620 mL |
10mM | 0.1691 mL | 0.8453 mL | 1.6905 mL | 3.3810 mL |
20mM | 0.0845 mL | 0.4226 mL | 0.8453 mL | 1.6905 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.